Metformin in esophageal carcinoma: exploring molecular mechanisms and therapeutic insights

SP Papadakos, A Argyrou, V Lekakis… - International Journal of …, 2024 - mdpi.com
Esophageal cancer (EC) remains a formidable malignancy with limited treatment options
and high mortality rates, necessitating the exploration of innovative therapeutic avenues …

Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the “Uncontrolled” in SARS-CoV-2

KI Papadopoulos, A Papadopoulou, TC Aw - Human Cell, 2024 - Springer
AXL is the gene that encodes the Anexelekto (AXL) receptor tyrosine kinase that
demonstrates significant roles in various cellular processes, including cell growth, survival …

Research progress on metformin in the treatment for malignant tumors

D Xueyu, L Binbin, LI Lei, Z Dingcai… - China …, 2024 - journal.china-pharmacy.com
In recent years, the potential anti-tumor effects of metformin have attracted widespread
attention in the field of cancer treatment. This article summarizes the research progress of …

二甲双胍在恶性肿瘤治疗中的研究进展

段雪玉, 廖彬彬, **蕾, 张鼎才, 陈瑞祥… - ** …, 2024 - journal.china-pharmacy.com
**年来二甲双胍潜在的抗肿瘤效果在肿瘤治疗领域引起了广泛关注. 本文综述了二甲双胍在恶性
肿瘤治疗中的研究进展, 发现其在消化系统恶性肿瘤(胆道癌, 胃癌, 食管癌, 结直肠癌, 胰腺癌 …